Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

A micellar on-pathway intermediate step explains the kinetics of prion amyloid formation.

Hingant E, Fontes P, Alvarez-Martinez MT, Arnaud JD, Liautard JP, Pujo-Menjouet L.

PLoS Comput Biol. 2014 Aug 7;10(8):e1003735. doi: 10.1371/journal.pcbi.1003735. eCollection 2014 Aug.

2.

Dynamics of polymerization shed light on the mechanisms that lead to multiple amyloid structures of the prion protein.

Alvarez-Martinez MT, Fontes P, Zomosa-Signoret V, Arnaud JD, Hingant E, Pujo-Menjouet L, Liautard JP.

Biochim Biophys Acta. 2011 Oct;1814(10):1305-17. doi: 10.1016/j.bbapap.2011.05.016. Epub 2011 Jun 16.

PMID:
21683809
3.

Physiological role of the cellular prion protein.

Zomosa-Signoret V, Arnaud JD, Fontes P, Alvarez-Martinez MT, Liautard JP.

Vet Res. 2008 Jul-Aug;39(4):9. Epub 2007 Nov 27. Review.

4.

Identification and isolation of Brucella suis virulence genes involved in resistance to the human innate immune system.

Liautard J, Ouahrani-Bettache S, Jubier-Maurin V, Lafont V, Köhler S, Liautard JP.

Infect Immun. 2007 Nov;75(11):5167-74. Epub 2007 Aug 20.

5.

Brucella suis histidinol dehydrogenase: synthesis and inhibition studies of a series of substituted benzylic ketones derived from histidine.

Abdo MR, Joseph P, Boigegrain RA, Liautard JP, Montero JL, Köhler S, Winum JY.

Bioorg Med Chem. 2007 Jul 1;15(13):4427-33. Epub 2007 Apr 24.

PMID:
17481905
6.

Different roles of the two high-oxygen-affinity terminal oxidases of Brucella suis: Cytochrome c oxidase, but not ubiquinol oxidase, is required for persistence in mice.

Jiménez de Bagüés MP, Loisel-Meyer S, Liautard JP, Jubier-Maurin V.

Infect Immun. 2007 Jan;75(1):531-5. Epub 2006 Nov 13.

7.

Release of LL-37 by activated human Vgamma9Vdelta2 T cells: a microbicidal weapon against Brucella suis.

Dudal S, Turriere C, Bessoles S, Fontes P, Sanchez F, Liautard J, Liautard JP, Lafont V.

J Immunol. 2006 Oct 15;177(8):5533-9.

8.

Requirement of norD for Brucella suis virulence in a murine model of in vitro and in vivo infection.

Loisel-Meyer S, Jiménez de Bagüés MP, Bassères E, Dornand J, Köhler S, Liautard JP, Jubier-Maurin V.

Infect Immun. 2006 Mar;74(3):1973-6.

9.

Antimicrobials: targeting virulence genes necessary for intracellular multiplication.

Liautard JP, Jubier-Maurin V, Boigegrain RA, Köhler S.

Trends Microbiol. 2006 Mar;14(3):109-13. Epub 2006 Feb 15.

PMID:
16469497
10.

Modulation of prion protein structure by pressure and temperature.

Torrent J, Alvarez-Martinez MT, Liautard JP, Lange R.

Biochim Biophys Acta. 2006 Mar;1764(3):546-51. Epub 2005 Nov 15. Review.

PMID:
16298177
11.

Differential use of the two high-oxygen-affinity terminal oxidases of Brucella suis for in vitro and intramacrophagic multiplication.

Loisel-Meyer S, Jiménez de Bagüés MP, Köhler S, Liautard JP, Jubier-Maurin V.

Infect Immun. 2005 Nov;73(11):7768-71.

12.

Analysis of the behavior of eryC mutants of Brucella suis attenuated in macrophages.

Burkhardt S, Jiménez de Bagüés MP, Liautard JP, Köhler S.

Infect Immun. 2005 Oct;73(10):6782-90.

13.

Absence of evidence for the participation of the macrophage cellular prion protein in infection with Brucella suis.

Fontes P, Alvarez-Martinez MT, Gross A, Carnaud C, Köhler S, Liautard JP.

Infect Immun. 2005 Oct;73(10):6229-36.

14.
15.

From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis.

Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, Walravens K, Garin-Bastuji B, Letesson JJ.

Vet Res. 2005 May-Jun;36(3):313-26. Review.

16.

The role of the 132-160 region in prion protein conformational transitions.

Torrent J, Alvarez-Martinez MT, Liautard JP, Balny C, Lange R.

Protein Sci. 2005 Apr;14(4):956-67.

17.

Vgamma9Vdelta2 T cells use a combination of mechanisms to limit the spread of the pathogenic bacteria Brucella.

Oliaro J, Dudal S, Liautard J, Andrault JB, Liautard JP, Lafont V.

J Leukoc Biol. 2005 May;77(5):652-60. Epub 2005 Jan 24.

PMID:
15668339
18.

Synthesis of prenyl pyrophosphonates as new potent phosphoantigens inducing selective activation of human Vgamma9Vdelta2 T lymphocytes.

Zgani I, Menut C, Seman M, Gallois V, Laffont V, Liautard J, Liautard JP, Criton M, Montero JL.

J Med Chem. 2004 Aug 26;47(18):4600-12.

PMID:
15317470
19.

High pressure induces scrapie-like prion protein misfolding and amyloid fibril formation.

Torrent J, Alvarez-Martinez MT, Harricane MC, Heitz F, Liautard JP, Balny C, Lange R.

Biochemistry. 2004 Jun 8;43(22):7162-70.

PMID:
15170353
20.

Impairment of intramacrophagic Brucella suis multiplication by human natural killer cells through a contact-dependent mechanism.

Dornand J, Lafont V, Oliaro J, Terraza A, Castaneda-Roldan E, Liautard JP.

Infect Immun. 2004 Apr;72(4):2303-11.

21.

Specific signaling pathways triggered by IL-2 in human V gamma 9V delta 2 T cells: an amalgamation of NK and alpha beta T cell signaling.

Lafont V, Loisel S, Liautard J, Dudal S, Sablé-Teychené M, Liautard JP, Favero J.

J Immunol. 2003 Nov 15;171(10):5225-32.

22.

What is the nature of the replicative niche of a stealthy bug named Brucella?

Köhler S, Michaux-Charachon S, Porte F, Ramuz M, Liautard JP.

Trends Microbiol. 2003 May;11(5):215-9.

PMID:
12781524
23.
24.
25.

Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.

Alvarez-Martinez MT, Torrent J, Lange R, Verdier JM, Balny C, Liautard JP.

Biochim Biophys Acta. 2003 Feb 21;1645(2):228-40.

PMID:
12573253
26.

Alternative prion structural changes revealed by high pressure.

Torrent J, Alvarez-Martinez MT, Heitz F, Liautard JP, Balny C, Lange R.

Biochemistry. 2003 Feb 11;42(5):1318-25.

PMID:
12564935
27.

The analysis of the intramacrophagic virulome of Brucella suis deciphers the environment encountered by the pathogen inside the macrophage host cell.

Kohler S, Foulongne V, Ouahrani-Bettache S, Bourg G, Teyssier J, Ramuz M, Liautard JP.

Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15711-6. Epub 2002 Nov 18.

28.

The innate immune response against Brucella in humans.

Dornand J, Gross A, Lafont V, Liautard J, Oliaro J, Liautard JP.

Vet Microbiol. 2002 Dec 20;90(1-4):383-94. Review.

PMID:
12414158
29.

Type IV secretion and Brucella virulence.

Boschiroli ML, Ouahrani-Bettache S, Foulongne V, Michaux-Charachon S, Bourg G, Allardet-Servent A, Cazevieille C, Lavigne JP, Liautard JP, Ramuz M, O'Callaghan D.

Vet Microbiol. 2002 Dec 20;90(1-4):341-8. Review.

PMID:
12414154
30.

The intramacrophagic environment of Brucella suis and bacterial response.

Köhler S, Porte F, Jubier-Maurin V, Ouahrani-Bettache S, Teyssier J, Liautard JP.

Vet Microbiol. 2002 Dec 20;90(1-4):299-309.

PMID:
12414150
31.

[Biology of the transmissible agent responsible for subacute spongiform encephalopathies].

Dormont D, Liautard JP.

Rev Prat. 1999 May 1;49(9):934-41. Review. French.

PMID:
11865457
32.

Induction of dnaK through its native heat shock promoter is necessary for intramacrophagic replication of Brucella suis.

Köhler S, Ekaza E, Paquet JY, Walravens K, Teyssier J, Godfroid J, Liautard JP.

Infect Immun. 2002 Mar;70(3):1631-4.

33.

The Brucella suis virB operon is induced intracellularly in macrophages.

Boschiroli ML, Ouahrani-Bettache S, Foulongne V, Michaux-Charachon S, Bourg G, Allardet-Servent A, Cazevieille C, Liautard JP, Ramuz M, O'Callaghan D.

Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1544-9.

34.
35.

Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages.

Jubier-Maurin V, Boigegrain RA, Cloeckaert A, Gross A, Alvarez-Martinez MT, Terraza A, Liautard J, Köhler S, Rouot B, Dornand J, Liautard JP.

Infect Immun. 2001 Aug;69(8):4823-30.

37.

Intracellular survival of Brucella spp. in human monocytes involves conventional uptake but special phagosomes.

Rittig MG, Alvarez-Martinez MT, Porte F, Liautard JP, Rouot B.

Infect Immun. 2001 Jun;69(6):3995-4006.

38.
39.

Characterization of Brucella suis clpB and clpAB mutants and participation of the genes in stress responses.

Ekaza E, Teyssier J, Ouahrani-Bettache S, Liautard JP, Köhler S.

J Bacteriol. 2001 Apr;183(8):2677-81.

40.
41.

Secretion of listeriolysin by Brucella suis inhibits its intramacrophagic replication.

Köhler S, Layssac M, Naroeni A, Gentschev I, Rittig M, Liautard JP.

Infect Immun. 2001 Apr;69(4):2753-6.

42.

Identification of the nik gene cluster of Brucella suis: regulation and contribution to urease activity.

Jubier-Maurin V, Rodrigue A, Ouahrani-Bettache S, Layssac M, Mandrand-Berthelot MA, Köhler S, Liautard JP.

J Bacteriol. 2001 Jan;183(2):426-34.

44.

Brucella suis-impaired specific recognition of phagosomes by lysosomes due to phagosomal membrane modifications.

Naroeni A, Jouy N, Ouahrani-Bettache S, Liautard JP, Porte F.

Infect Immun. 2001 Jan;69(1):486-93.

45.
46.
47.

Functional analysis of the ClpATPase ClpA of Brucella suis, and persistence of a knockout mutant in BALB/c mice.

Ekaza E, Guilloteau L, Teyssier J, Liautard JP, Köhler S.

Microbiology. 2000 Jul;146 ( Pt 7):1605-16.

PMID:
10878125
48.

Analytical background and discussion of the chaperone model of prion diseases.

Liautard JP.

Acta Biotheor. 1999;47(3-4):219-38.

PMID:
10855269
49.

Early events and implication of F-actin and annexin I associated structures in the phagocytic uptake of Brucella suis by the J-774A.1 murine cell line and human monocytes.

Kusumawati A, Cazevieille C, Porte F, Bettache S, Liautard JP, Sri Widada J.

Microb Pathog. 2000 Jun;28(6):343-52.

PMID:
10839971
50.

Tumor necrosis factor-alpha production is differently regulated in gamma delta and alpha beta human T lymphocytes.

Lafont V, Liautard J, Gross A, Liautard JP, Favero J.

J Biol Chem. 2000 Jun 23;275(25):19282-7.

Supplemental Content

Loading ...
Support Center